Analysen zu Reckitt Benckiser Plc
| 23.04.24 | Reckitt Benckiser Hold | Jefferies & Company Inc. | |
| 22.04.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 18.04.24 | Reckitt Benckiser Overweight | Barclays Capital | |
| 05.04.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 02.04.24 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 02.04.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 28.03.24 | Reckitt Benckiser Overweight | Barclays Capital | |
| 28.03.24 | Reckitt Benckiser Buy | UBS AG | |
| 27.03.24 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
| 19.03.24 | Reckitt Benckiser Buy | UBS AG | |
| 19.03.24 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
| 18.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 18.03.24 | Reckitt Benckiser Buy | UBS AG | |
| 18.03.24 | Reckitt Benckiser Overweight | Barclays Capital | |
| 18.03.24 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 18.03.24 | Reckitt Benckiser Outperform | Bernstein Research | |
| 18.03.24 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
| 18.03.24 | Reckitt Benckiser Neutral | Goldman Sachs Group Inc. | |
| 15.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 11.03.24 | Reckitt Benckiser Neutral | Goldman Sachs Group Inc. | |
| 08.03.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 06.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 04.03.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 01.03.24 | Reckitt Benckiser Kaufen | DZ BANK | |
| 01.03.24 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 29.02.24 | Reckitt Benckiser Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.02.24 | Reckitt Benckiser Overweight | Barclays Capital | |
| 29.02.24 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 28.02.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 28.02.24 | Reckitt Benckiser Buy | UBS AG | |
| 28.02.24 | Reckitt Benckiser Outperform | Bernstein Research | |
| 28.02.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 28.02.24 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
| 28.02.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 28.02.24 | Reckitt Benckiser Overweight | Barclays Capital | |
| 27.02.24 | Reckitt Benckiser Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.02.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 22.02.24 | Reckitt Benckiser Underperform | Jefferies & Company Inc. |
Aktuelle Aktienanalysen
| 13.02.26 | Mercedes-Benz Group Market-Perform | Bernstein Research | |
| 13.02.26 | L'Oréal Market-Perform | Bernstein Research | |
| 13.02.26 | Daimler Truck Outperform | RBC Capital Markets | |
| 13.02.26 | SAFRAN Outperform | Bernstein Research | |
| 13.02.26 | Siemens Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | Volvo AB Sector Perform | RBC Capital Markets | |
| 13.02.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | UniCredit Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | Santander Buy | Goldman Sachs Group Inc. | |
| 13.02.26 | RELX Buy | UBS AG | |
| 13.02.26 | AB InBev Buy | UBS AG | |
| 13.02.26 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 13.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 13.02.26 | JENOPTIK Neutral | UBS AG | |
| 13.02.26 | Mercedes-Benz Group Hold | Jefferies & Company Inc. | |
| 13.02.26 | Mercedes-Benz Group Equal Weight | Barclays Capital | |
| 13.02.26 | GSK Buy | Jefferies & Company Inc. | |
| 13.02.26 | Adyen B.V. Parts Sociales Buy | UBS AG | |
| 13.02.26 | SAFRAN Neutral | UBS AG | |
| 13.02.26 | Siltronic Neutral | UBS AG | |
| 13.02.26 | L'Oréal Overweight | Barclays Capital | |
| 13.02.26 | L'Oréal Buy | UBS AG | |
| 13.02.26 | RELX Overweight | Barclays Capital | |
| 13.02.26 | EssilorLuxottica Overweight | Barclays Capital | |
| 13.02.26 | AB InBev Overweight | Barclays Capital | |
| 13.02.26 | Unilever Overweight | Barclays Capital | |
| 13.02.26 | Deutsche Börse Overweight | Barclays Capital | |
| 13.02.26 | Hermès Neutral | UBS AG | |
| 13.02.26 | Siemens Underweight | Barclays Capital | |
| 13.02.26 | Carl Zeiss Meditec Equal Weight | Barclays Capital | |
| 13.02.26 | Hennes & Mauritz AB Underweight | Barclays Capital | |
| 13.02.26 | SAFRAN Buy | Goldman Sachs Group Inc. | |
| 13.02.26 | JENOPTIK Buy | Warburg Research | |
| 13.02.26 | JENOPTIK Buy | Jefferies & Company Inc. | |
| 13.02.26 | SAFRAN Buy | Jefferies & Company Inc. | |
| 13.02.26 | SAFRAN Outperform | RBC Capital Markets | |
| 13.02.26 | Delivery Hero Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | RWE Market-Perform | Bernstein Research | |
| 13.02.26 | AUTO1 Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | Adyen B.V. Parts Sociales Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | Adyen B.V. Parts Sociales Buy | Jefferies & Company Inc. | |
| 12.02.26 | EssilorLuxottica Buy | Jefferies & Company Inc. | |
| 12.02.26 | Commerzbank Sector Perform | RBC Capital Markets | |
| 12.02.26 | AB InBev Buy | Jefferies & Company Inc. | |
| 12.02.26 | L'Oréal Outperform | RBC Capital Markets | |
| 12.02.26 | Siltronic Buy | Jefferies & Company Inc. | |
| 12.02.26 | Hermès Neutral | JP Morgan Chase & Co. | |
| 12.02.26 | Adyen B.V. Parts Sociales Kaufen | DZ BANK | |
| 12.02.26 | EssilorLuxottica Kaufen | DZ BANK | |
| 12.02.26 | Unilever Underperform | RBC Capital Markets |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.